RxMen, a Delhi-based men’s health tech startup, raised $570K seed funding led by Inflection Point Ventures. Founded by Shailja Mittal in 2023, it focuses on root-cause treatment for sexual health, hormones, and stress. Funds will drive brand building, product launches, and clinics, targeting EBITDA positivity by Oct 2025. Reporting 100x growth, $70K MRR, and 30K consultations, RxMen projects $1.7M ARR by FY26, competing with Man Matters and Bold Care.
Trending
- Acko Taps Top Banks for H1 2027 IPO Target
- Fairdeal.Market Secures US$15M to Scale B2B Quick Commerce Across India
- India’s Startup IPO Surge: 48+ Listings Set to Unlock INR 50,000 Cr in 2026
- Indian Startup IPO Surge Expected by 2026 Amid Market Reset
- IIT Madras Director Unfazed by India’s AI Sovereignty Concerns
- Flipkart Bolsters Leadership with Key VP Appointments
- IEA Warns Current Oil Crisis Exceeds Past Shocks
- HomeEssentials Secures $7.7M to Fuel Retail Expansion


